| local |
routine |
diagnosis |
|
|
|
|
|
|
|
|
|
|
adults
|
681
(82.5%)
|
serum
|
adults
|
U250
|
56.0 ± 16.7
(20-94)
|
4.97 [2.08; 17.4]
|
(57.8%)
4.79
[2.1; 16.6]
|
(42.2%)
5.47
[2.2; 17.7]
NS
|
6 (0.9%)
|
147 (21.6%)
|
76 (11.2%)
|
|
children teenagers
|
143 (17.3%)
|
serum
|
children teenagers
|
U250
|
10.4 ± 6.2
(0-20)
|
4.71 [2.14; 18.1]
|
(42.7%)
4.21
[2.1; 11.5]
|
(57.3%)
5.06
[2.2; 19.1]
NS
|
0
|
26
(18.2%)
|
16 (11.2%)
|
| Interlab |
healthy |
donors |
(HD) |
|
|
|
|
|
|
|
|
|
7 labs
|
636
|
serum
|
adults
|
U250
|
49.3 ± 17.9
(18-95)
|
4.4
[2.0; 9.0]
|
(56.5%)
4.6
[2.2; 8.8]
|
(43.5%)
4.7
[2.0; 9.1]
NS
|
3 (0.47%)
|
50 (7.9%)
|
7(1.1%) [12.5-20.3]
|
|
1 lab
|
54
|
Plasma
|
adults
|
U250
|
NA
|
4.0
[1.7; 10.2]
NS
|
NA
|
NA
|
0
|
6 (11.1%)
|
2 (3.7%)
[14.9-20.0]
|
|
1 lab
|
27
|
serum
|
adults
|
U100
|
55.5 ± 24.4
(18-95)
|
3.4
[1.9; 7.3]
NS
|
(48.1%)
4.0
[2.0; 7.0]
|
(51.9%)
3.4
[18; 10.8]
NS
|
0
|
1 (3.7%)
|
1 (3.7%) [17.6]
|
|
3 labs
|
56
|
serum
|
teenagers
|
U100 (6)
U250 (50)
|
15.8 ± 1.62
(10-117.9)
|
2.6
[1.2-5.3]
p<0.001
|
(46.4%)
2.7
[1.2; 5.3]
|
[53.6%)
2.6
[1.3; 5.1]
NS
|
0
|
1 (1.8%) [8.3]
|
0
|
|
1 lab
|
15
|
serum
|
children
|
U100
|
3.9 ± 2.55 (1-9)
|
5.0
[3.2; 11.1]
p=0.0184
|
(20%)
5.0
[4.3-7.5]
|
(80%)
5.0
[3.2; -11.5]
NS
|
0
|
3 (20%)
|
1(6.7%)
[13,0]
|
|
1 lab
|
51
|
serum
|
new borns
|
U250
|
3days
|
6.0
[2.5;13.2]
p<0.0001
|
(56.9%)
5.3
[2.6-9.0)]
NS
|
(43.1%)
6.1
[4.2; 11.1]
p=0.034
|
0
|
10 (19.6%)
|
2 (3.9%)[11.6-13.2]
|